David Ridley

David Ridley

Senior Editor

Conventry, UK

David's coverage specializes in OTC medicines, dietary supplements and self-care medical devices. David is interested in regulatory gray areas such as the borderlines between medicines, supplements and medical devices, as well as botanical ingredients. David also regularly speaks to industry leaders and experts about the latest trends to deliver crucial market intelligence to HBW Insight readers, and co-hosts the Over the Counter podcast. In his spare time, David spends time in his allotment garden, reading/watching science fiction and worrying about climate change.

Latest from David Ridley

Haleon Partners With Bower App To Help UK Consumers Recycle Toothpaste Tubes

In return for scanning and recycling toothpaste products, UK consumers will be able to collect points which they can then convert into cash, coupons or charity donations, thanks to a partnership between Haleon and the Bower recycling app.

FAO/WHO Codex Alimentarius Committee: Harmonized Guidelines for Probiotics?

At its most recent meeting, delegates to the Food and Agriculture Organization of the United Nations and World Health Organization’s Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) discussed international harmonization guidelines for probiotics as constituents in foods and dietary supplements, based on a proposal to align international regulatory frameworks with guidelines established by the FAO/WHO.

German OTC Marketing News: Launches From Bayer, Stada, Hermes And Klosterfrau

Bayer adds dry eye treatment to its Bepanthen skin care range; Stada launches special edition Elotrans supplement for Eintracht Frankfurt fans; Hermes offers chewable magnesium supplement; and Klosterfrau introduces Oyono Night extension to help troubled sleepers maintain their immunity.

UK’s ProBiotix Strikes Probiotic Distribution Deals In Ukraine And Greece

ProBiotix Health has announced two commercial partnerships for the distribution of its probiotic ingredients, with Deutsch-Pharm in Ukraine and Eifron in Greece respectively.

PAGB ‘State Of The Nation’ Report: Rx-To-OTC Switch Should Be Priority For UK Gov

UK consumer healthcare industry association PAGB is calling on the UK government to explore the Rx-to-OTC switch of at least 25 OTC products over five years, and work with the country's medicines agency to re-evaluate the restrictive criteria for reclassification. 

‘The Possibilities Are Limitless’ – How Bayer CH Is Using AI To Drive Internal Efficiency

In addition to its recently established Precision Health division, Bayer Consumer Health is using artificial intelligence to save time on routine tasks and to manage supply and demand, the firm’s head of digital transformation and IT, Cristina Nitulescu, tells HBW Insight.